| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |